date,title,source
Oct-17-18,What Kind Of Risk Should You Expect For Arbutus Biopharma Corporation (NASDAQ:ABUS)?,Simply Wall St.
Oct-19-18,"New Research Coverage Highlights Arbutus Biopharma, Tata Motors, Core-Mark Holding, Tenaris S.A, Addus HomeCare, and ZTO Express (Cayman)  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-22-18,Arbutus Names New Members to its Board of Directors,GlobeNewswire
Oct-31-18,Arbutus to Report Third Quarter 2018 Financial Results,GlobeNewswire
Nov-07-18,Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update,GlobeNewswire
Nov-21-18,Options Traders Expect Huge Moves in Arbutus (ABUS) Stock,Zacks
Nov-26-18,Arbutus Appoints Dr. Frank Torti as Chairman of its Board of Directors,GlobeNewswire
Dec-11-18,"New Research Coverage Highlights Nokia, SecureWorks, National Western Life Group, Brookfield Asset Management, FormFactor, and Arbutus Biopharma  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Jan-22-19,Can We See Significant Insider Ownership On The Arbutus Biopharma Corporation (NASDAQ:ABUS) Share Register?,Simply Wall St.
Feb-04-19,"Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Feb-28-19,Arbutus to Report Fourth Quarter and Year-End 2018 Financial Results and Provide Corporate Update,GlobeNewswire
Mar-07-19,Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives,GlobeNewswire
Apr-04-19,Arbutus Biopharma Corporation (NASDAQ:ABUS): Will The Growth Last?,Simply Wall St.
Apr-08-19,Top Ranked Momentum Stocks to Buy for April 8th,Zacks
Apr-11-19,4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics,Zacks
Apr-25-19,Arbutus Biopharma (ABUS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release,Zacks
Apr-29-19,Arbutus to Report First Quarter 2019 Financial Results,GlobeNewswire
May-06-19,"Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates",Zacks
May-06-19,Arbutus: 1Q Earnings Snapshot,Associated Press
May-06-19,Arbutus Reports First Quarter 2019 Financial Results and Provides Corporate Update,GlobeNewswire
May-13-19,Arbutus to Present at Upcoming May 2019 Conferences,GlobeNewswire
May-22-19,Is Arbutus Biopharma Corporation (NASDAQ:ABUS) Excessively Paying Its CEO?,Simply Wall St.
Jun-13-19,Arbutus to Participate at JMP Securities Life Sciences Conference,GlobeNewswire
Jun-17-19,"Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.",GlobeNewswire
Jun-20-19,Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729,GlobeNewswire
Jun-21-19,"Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up",Zacks
